康辰药业(603590)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

603590 康辰药业

交易中 04-19 13:48:41

{"stockData":{"symbol":"603590","market":"SH","secType":"STK","nameCN":"康辰药业","latestPrice":28.47,"timestamp":1713505721000,"preClose":28.54,"halted":0,"volume":728100,"delay":0,"floatShares":158000000,"shares":160000000,"eps":0.9154,"marketStatus":"交易中","marketStatusCode":2,"change":-0.07,"latestTime":"04-19 13:48:41","open":28.27,"high":28.75,"low":28.22,"amount":20743800,"amplitude":0.0186,"askPrice":28.47,"askSize":1,"bidPrice":28.46,"bidSize":8,"shortable":0,"etf":0,"ttmEps":0.9154,"tradingStatus":2,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1713510000000},"adr":0,"adjPreClose":28.54,"symbolType":"stock","openAndCloseTimeList":[[1713490200000,1713497400000],[1713502800000,1713510000000]],"highLimit":31.39,"lowLimit":25.69,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":160000000,"pbRate":1.46,"roa":"--","roe":"4.94%","epsLYR":0.65,"committee":0.363636,"marketValue":4555000000,"floatMarketCap":4484000000,"peRate":31.101157,"changeRate":-0.0025,"turnoverRate":0.0046,"status":1},"requestUrl":"/m/hq/s/603590","defaultTab":"news","newsList":[{"id":"2428553365","title":"康辰药业04月18日主力资金流入12万元 连续5日加仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2428553365","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2428553365?lang=zh_cn&edition=full","pubTime":"2024-04-18 15:19","pubTimestamp":1713424775,"startTime":"0","endTime":"0","summary":"04月18日, 康辰药业股价跌0.76%，报收28.54元，成交金额3660万元，换手率0.81%，振幅2.99%，量比0.80。康辰药业今日主力资金净流入12万元，连续5日净流入，上一交易日主力净流入140万元，今日环比减少91.43%。该股近5个交易日下跌2.69%，主力资金累计净流入299万元；近20日主力资金累计净流出689万元，其中净流出天数为9日。该行业中净流入前三个股分别为上海莱士、华兰生物、西藏药业。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240418153358878eaa97&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240418153358878eaa97&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2428331911","title":"北向资金4月16日净卖出康辰药业13.72万股 连续3日减持","url":"https://stock-news.laohu8.com/highlight/detail?id=2428331911","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2428331911?lang=zh_cn&edition=full","pubTime":"2024-04-17 09:30","pubTimestamp":1713317429,"startTime":"0","endTime":"0","summary":"4月16日，北向资金减持康辰药业13.72万股连续3日减持。截止当日收盘，沪股通共持有康辰药业35.96万股，占流通股0.22%。沪股通减持金额前五个股分别为宇通客车、中国石油、中国神华、万华化学、中信银行。康辰药业近5个交易日下跌13.16%，沪股通累计减持4.00万股；近20个交易日下跌10.71%，沪股通累计减持34.89万股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404170936218b2ca57b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404170936218b2ca57b&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2427149338","title":"康辰药业04月16日主力资金流入31万元 连续3日加仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2427149338","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2427149338?lang=zh_cn&edition=full","pubTime":"2024-04-16 15:19","pubTimestamp":1713251973,"startTime":"0","endTime":"0","summary":"04月16日, 康辰药业股价跌3.06%，报收27.52元，成交金额4999万元，换手率1.15%，振幅4.68%，量比0.90。康辰药业今日主力资金净流入31万元，连续3日净流入，上一交易日主力净流入92万元，今日环比减少66.30%。近一年数据显示，该股主力连续3日净流入后，次日上涨概率为75.00%，平均涨幅为2.46%。该股近5个交易日下跌13.16%，主力资金累计净流出509万元；近20日主力资金累计净流出593万元，其中净流出天数为9日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404161542468783311e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404161542468783311e&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2426137249","title":"北向资金4月11日净买入康辰药业15.85万股 连续3日增持","url":"https://stock-news.laohu8.com/highlight/detail?id=2426137249","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2426137249?lang=zh_cn&edition=full","pubTime":"2024-04-12 09:30","pubTimestamp":1712885426,"startTime":"0","endTime":"0","summary":"4月11日, 北向资金增持康辰药业15.85万股，连续3日增持。截止当日收盘，沪股通共持有康辰药业60.16万股，占流通股0.38%。沪股通增持金额前五个股分别为兆易创新、赤峰黄金、三六零、山东黄金、海螺水泥。康辰药业近5个交易日下跌6.11%，沪股通累计增持28.52万股；近20个交易日下跌2.23%，沪股通累计减持33.41万股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240412093407876b6b0d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240412093407876b6b0d&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2426034174","title":"深度*公司*康辰药业(603590)：利润端增势强劲 多项目研发管线进展顺利","url":"https://stock-news.laohu8.com/highlight/detail?id=2426034174","media":"中银国际证券股...","top":-1,"share":"https://www.laohu8.com/m/news/2426034174?lang=zh_cn&edition=full","pubTime":"2024-04-11 11:07","pubTimestamp":1712804843,"startTime":"0","endTime":"0","summary":"公司近日发布2023 年度业绩快报，2023 年公司实现营业收入9.20 亿元，同比增长6.15%，实现归母净利润1.50 亿元，同比增长48.24%，利润端增长强劲，“苏灵”获医保续约和解限贡献业绩增量，未来创新药成果逐步兑现，有望助力公司实现强劲增长，维持买入评级。支撑评级的要点利润端增速亮眼，“苏灵”持续放量。“苏灵”获得医保续约和解限，市场准入优势进一步扩大，而且公司后续采取一系列举措，提升药物可及性，借此实现较快放量。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041111072987650933&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041111072987650933&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2426559450","title":"4月10日康辰药业跌5.30%，中信卓越成长两年持有混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2426559450","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2426559450?lang=zh_cn&edition=full","pubTime":"2024-04-10 17:45","pubTimestamp":1712742320,"startTime":"0","endTime":"0","summary":"证券之星消息，4月10日康辰药业跌5.30%，收盘报30.01元，换手率1.33%，成交量2.09万手，成交额6359.25万元。根据2023基金年报公募基金重仓股数据，重仓该股的公募基金共9家，其中持有数量最多的公募基金为中信卓越成长两年持有混合A。中信卓越成长两年持有混合A的前十大重仓股如下：以上内容由证券之星根据公开信息整理，由算法生成，与本站立场无关。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404101746228b0952b2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404101746228b0952b2&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2426827164","title":"康辰药业大跌5.05% 12家券商给予买入建议","url":"https://stock-news.laohu8.com/highlight/detail?id=2426827164","media":"智选洞察","top":-1,"share":"https://www.laohu8.com/m/news/2426827164?lang=zh_cn&edition=full","pubTime":"2024-04-10 13:10","pubTimestamp":1712725824,"startTime":"0","endTime":"0","summary":"04月10日，康辰药业股价大幅下跌，截至13点10分，康辰药业下跌5.05%，报30.09元/股，成交4006万元，换手率0.83%。资金动向截止发稿，康辰药业获得主力净流出232万元，其中超大单流出150万元，大单流出81万元。北向资金方面，康辰药业04月09日获得北向资金增持15.60万股，截至04月09日，北向资金当前共持有康辰药业39.96万股，市值1202万元，持股占流通股比为0.25%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404101310557a51cab6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404101310557a51cab6&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2426525421","title":"康辰药业“苏灵”产品放量2023年净利增48% 近6年研发费5.39亿核心创新产品顺利推进","url":"https://stock-news.laohu8.com/highlight/detail?id=2426525421","media":"长江商报","top":-1,"share":"https://www.laohu8.com/m/news/2426525421?lang=zh_cn&edition=full","pubTime":"2024-04-09 16:55","pubTimestamp":1712652937,"startTime":"0","endTime":"0","summary":"近年来，为了摆脱对苏灵的依赖，康辰药业通过收购进军骨科药品市场。财报显示，2018年至2022年，康辰药业研发费用分别为0.8亿元、1.09亿元、0.93亿元、1.02亿元和0.87亿元，2023年前三季度，公司研发费用为6722万元，研发费用率为9%。近6年时间公司研发费用累计达5.39亿元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240409165626875920a4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240409165626875920a4&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2426907216","title":"一季度业绩飙升：新农股份盈利翻近两倍，康辰药业增长50%至65%，甘肃能源扭亏为盈！","url":"https://stock-news.laohu8.com/highlight/detail?id=2426907216","media":"和讯网","top":-1,"share":"https://www.laohu8.com/m/news/2426907216?lang=zh_cn&edition=full","pubTime":"2024-04-09 10:10","pubTimestamp":1712628637,"startTime":"0","endTime":"0","summary":"中国中免一季度实现归母净利润23.08亿元，同比增长0.33%，营业收入188.07亿元，同比下滑9.45%。新农股份、江苏国信、莲花健康等公司盈利增幅显著。康辰药业预计一季度实现归母净利润3850.31万元至4235.34万元，同比增长50%至65%。晨鸣纸业预计一季度盈利5000万元至7000万元，上年同期亏损2.75亿元。舆情看点：1. 多家公司2024年一季度业绩预报显示盈利增长。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404091010428b00c40f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404091010428b00c40f&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2426909055","title":"北向资金4月8日净卖出康辰药业3.78万股 连续3日减持","url":"https://stock-news.laohu8.com/highlight/detail?id=2426909055","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2426909055?lang=zh_cn&edition=full","pubTime":"2024-04-09 09:30","pubTimestamp":1712626232,"startTime":"0","endTime":"0","summary":"4月8日，北向资金减持康辰药业3.78万股连续3日减持。截止当日收盘，沪股通共持有康辰药业24.36万股，占流通股0.15%。沪股通减持金额前五个股分别为贵州茅台、兖矿能源、中国中免、山东黄金、中海油服。康辰药业近5个交易日上涨0.23%，沪股通累计减持19.27万股；近20个交易日上涨3.16%，沪股通累计减持89.44万股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404090935278b00a518&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404090935278b00a518&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2425951239","title":"康辰药业2023年净利润增48.24% 苏灵产品市场优势扩大","url":"https://stock-news.laohu8.com/highlight/detail?id=2425951239","media":"观点新媒体","top":-1,"share":"https://www.laohu8.com/m/news/2425951239?lang=zh_cn&edition=full","pubTime":"2024-04-08 19:57","pubTimestamp":1712577444,"startTime":"0","endTime":"0","summary":"观点网讯：4月8日，北京康辰药业股份有限公司发布2023年度业绩快报公告。报告显示，康辰药业在报告期内实现营业总收入约9.20亿元，较上年同期的8.67亿元增长6.15%。归属于上市公司股东的净利润达到1.50亿元，同比大幅增长48.24%。康辰药业的营业利润和利润总额分别为1.43亿元和1.23亿元，较上年同期分别增长1.83%和下降12.53%。康辰药业表示，报告期内，公司“苏灵”产品获得医保续约和解限，市场准入优势扩大，带动销量增长。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240408195841875454ca&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240408195841875454ca&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2425993026","title":"康辰药业一季度预计实现净利3850.31万元到4235.34万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2425993026","media":"北京商报官方账号","top":-1,"share":"https://www.laohu8.com/m/news/2425993026?lang=zh_cn&edition=full","pubTime":"2024-04-08 19:54","pubTimestamp":1712577261,"startTime":"0","endTime":"0","summary":"北京商报讯（记者 丁宁）4月8日晚间，康辰药业（603590）发布公告称，公司预计2024年第一季度实现归属净利润为3850.31万元到4235.34万元，与上年同期（法定披露数据）相比增加1283.44万元到1668.47万元，同比增加50%到65%。康辰药业同时发布2023年业绩快报显示，2023年，公司实现营业收入约为9.2亿元，同比增加6.15%；对应实现的归属净利润1.5亿元，同比增长48.24%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404081955428afe7377&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404081955428afe7377&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2425962204","title":"康辰药业发布首季预增公告 净利润同比增长50.00%~65.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2425962204","media":"证券时报网","top":-1,"share":"https://www.laohu8.com/m/news/2425962204?lang=zh_cn&edition=full","pubTime":"2024-04-08 18:50","pubTimestamp":1712573434,"startTime":"0","endTime":"0","summary":"证券时报网讯，康辰药业(603590)4月8日发布首季业绩预增公告，预计实现净利润为3850.31万元~4235.34万元，净利润同比增长50.00%~65.00%。证券时报•数据宝统计显示，康辰药业今日收于30.66元，下跌2.51%，日换手率为0.54%，成交额为2639.06万元，近5日上涨0.23%。通过对首季业绩预增50%以上的个股走势进行统计发现，预告发布后当日股价上涨的占比73.68%，股价发布当日股价涨停的有1家。预告发布后5日股价上涨的占比57.89%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404081850388afe3f16&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404081850388afe3f16&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2425196911","title":"康辰药业(603590.SH)业绩快报：2023年度净利润1.5亿元 同比增长48.24%","url":"https://stock-news.laohu8.com/highlight/detail?id=2425196911","media":"格隆汇资讯","top":-1,"share":"https://www.laohu8.com/m/news/2425196911?lang=zh_cn&edition=full","pubTime":"2024-04-08 18:06","pubTimestamp":1712570815,"startTime":"0","endTime":"0","summary":"格隆汇4月8日丨康辰药业(603590.SH)公布2023年度业绩快报公告，报告期内，公司实现营业总收入9.2亿元，较上年同期增长6.15%；归属于上市公司股东的净利润1.5亿元，较上年同期增长48.24%；报告期内，公司主要在销产品“苏灵”获得了医保续约和解限，“苏灵”的市场准入优势进一步扩大，公司抓住机遇，采取一系列举措提升药物的可及性，将“苏灵”在疗效、安全性、药物经济学方面的优势传递到临床终端，“苏灵”销量的增长，致营业收入较上年同期增长。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404081807028753f85e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404081807028753f85e&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2425969439","title":"康辰药业：2024年第一季度净利润预增50%到65%","url":"https://stock-news.laohu8.com/highlight/detail?id=2425969439","media":"21世纪经济报道","top":-1,"share":"https://www.laohu8.com/m/news/2425969439?lang=zh_cn&edition=full","pubTime":"2024-04-08 18:05","pubTimestamp":1712570700,"startTime":"0","endTime":"0","summary":"南方财经4月8日电，康辰药业公告，预计2024年第一季度实现归属于母公司所有者的净利润为3,850.31万元到4,235.34万元，与上年同期(法定披露数据)相比增加1,283.44万元到1,668.47万元，同比增加50%到65%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404081805478753f731&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404081805478753f731&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2424896083","title":"【机构调研记录】兴合基金调研康辰药业、杭氧股份等3只个股（附名单）","url":"https://stock-news.laohu8.com/highlight/detail?id=2424896083","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2424896083?lang=zh_cn&edition=full","pubTime":"2024-04-04 08:59","pubTimestamp":1712192378,"startTime":"0","endTime":"0","summary":"旗下最近一年表现最佳的基金产品为兴合安平六个月持有债券A，最新单位净值为0.98，近一年增长-1.19%。以上内容由证券之星根据公开信息整理，由算法生成，与本站立场无关。证券之星力求但不保证该信息全部或者部分内容的的准确性、完整性、有效性、及时性等，如存在问题请联系我们。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024040409001887dca3ad&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024040409001887dca3ad&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2421850592","title":"康辰药业03月22日主力资金流出34万元 连续3日减仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2421850592","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2421850592?lang=zh_cn&edition=full","pubTime":"2024-03-22 15:18","pubTimestamp":1711091881,"startTime":"0","endTime":"0","summary":"03月22日, 康辰药业股价涨0.06%，报收31.42元，成交金额3953万元，换手率0.80%，振幅3.57%，量比0.92。康辰药业今日主力资金净流出34万元，连续3日净流出，上一交易日主力净流出142万元，今日环比减少76.06%。该股近5个交易日上涨1.95%，主力资金累计净流入39万元；近20日主力资金累计净流入3555万元，其中净流入天数为7日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403221527538b5471d1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403221527538b5471d1&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2421022185","title":"华金证券：给予康辰药业买入评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2421022185","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2421022185?lang=zh_cn&edition=full","pubTime":"2024-03-22 01:05","pubTimestamp":1711040735,"startTime":"0","endTime":"0","summary":"华金证券股份有限公司近期对康辰药业进行研究并发布了研究报告《在研管线逐步收获，金草片有望填补治疗空白》，本报告对康辰药业给出买入评级，当前股价为31.4元。康辰药业投资要点事件：2024年3月21日，公司公告称，公司中药创新药金草片在女性盆腔炎性疾病后遗症慢性盆腔痛患者中开展的多中心、随机、双盲、安慰剂平行对照Ⅲ期临床已达主要终点。最新盈利预测明细如下：该股最近90天内共有1家机构给出评级，买入评级1家。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403220106118b51cd56&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403220106118b51cd56&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2421049104","title":"康辰药业金草片Ⅲ期临床成功，治疗女性慢性盆腔痛疗效显著","url":"https://stock-news.laohu8.com/highlight/detail?id=2421049104","media":"和讯网","top":-1,"share":"https://www.laohu8.com/m/news/2421049104?lang=zh_cn&edition=full","pubTime":"2024-03-21 21:31","pubTimestamp":1711027910,"startTime":"0","endTime":"0","summary":"快讯正文康辰药业中药创新药金草片Ⅲ期临床试验成功康辰药业公布，金草片在女性盆腔炎性疾病后遗症慢性盆腔痛患者中进行的Ⅲ期临床试验已成功达到主要研究终点。试验采用多中心、随机、双盲、安慰剂对照设计，旨在评估金草片与安慰剂在治疗慢性盆腔痛方面的有效性和安全性。康辰药业将与监管部门沟通，推进金草片上市申请。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403212206338b51396c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403212206338b51396c&s=b","is_publish_highlight":false,"gpt_icon":0}],"profile":{"ret":0,"listingDate":"2018-08-27","address":"北京市密云区经济开发区兴盛南路11号","stockEarnings":[{"period":"1week","weight":-0.0269},{"period":"1month","weight":-0.0885},{"period":"3month","weight":-0.1293},{"period":"6month","weight":-0.2157},{"period":"1year","weight":-0.2005},{"period":"ytd","weight":-0.2505}],"companyName":"北京康辰药业股份有限公司","boardCode":"AI0027","perCapita":"13676股","boardName":"医药制造业","registeredCapital":"16000万元","compareEarnings":[{"period":"1week","weight":0.0132},{"period":"1month","weight":0.0037},{"period":"3month","weight":0.0854},{"period":"6month","weight":0.0306},{"period":"1year","weight":-0.0878},{"period":"ytd","weight":0.0334}],"survey":"　　北京康辰药业股份有限公司的主营业务是一家坚持以创新药研发为核心、以临床需求为导向，集研发、生产和销售于一体。目前公司产品和在研产品主要专注于血液、骨科以及肿瘤等市场空间较大的领域。公司主要产品“苏灵”是目前国内血凝酶制剂市场唯一的国家一类新药。","serverTime":1713505732545,"listedPrice":24.34,"stockholders":"11517人(较上一季度增加4.58%)","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"康辰药业(603590)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供康辰药业(603590)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"康辰药业,603590,康辰药业股票,康辰药业股票老虎,康辰药业股票老虎国际,康辰药业行情,康辰药业股票行情,康辰药业股价,康辰药业股市,康辰药业股票价格,康辰药业股票交易,康辰药业股票购买,康辰药业股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"康辰药业(603590)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供康辰药业(603590)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}